Search Results 161-170 of 19692 for Receptor

  1. Lapatinib (oral route) - Side effects & dosage - Mayo Clinic

    Lapatinib is also used together with letrozole to treat postmenopausal women with hormone-receptor positive and HER2-receptor positive metastatic breast cancer.

  2. Stephen A. Boorjian, M.D. - Mayo Clinic Faculty Profiles

    His work in particular focuses on study of the steroid hormone receptor pathways in these cancers, specifically the androgen receptor. Targeting the ...

  3. Triple-Negative Breast Cancer Clinical Trials - Mayo Clinic Research

    ... receptor positive triple-negative breast cancer that has spread to other ... Enzalutamide may stop the growth of tumor cells by blocking the androgen receptor ...

  4. TUESDAY Q & A: Treatment plan should be based on specific type of breast cancer

    This type of cancer is characterized by the presence of estrogen receptors. If a tumor is estrogen receptor (ER) positive, that means the breast cancer cells ...

  5. Publications - Rouzbeh Mashayekhi, M.D., M.P.H. - Mayo Clinic

    G Protein-coupled receptor kinase 5 is localized to centrosomes and regulates cell cycle progression. J Biol Chem. 2012 Feb 24; 287 (9):6928-40 Epub 2012 ...

  6. Elacestrant (oral route) - Mayo Clinic

    Elacestrant is used to treat estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR-1 mutated, advanced or ...

  7. A Study to Evaluate the Effect of Medical Intervention on Sinonasal Inflammation in Patients with Chronic Sinusitis, Nasal Polyps and Positive Sinus Culture - Mayo Clinic

    ... receptor antagonist, and interleukin 5 receptor antagonist following endoscopic sinus surgery versus control in patient with chronic sinusitis with nasal ...

  8. Claudia Manriquez Roman: CAR-T Cell Therapy for Cancer - Student Research - Mayo Clinic College of Medicine & Science

    I found similar results depleting a specific receptor involved in the apoptotic pathway. I also found tumor cells pre-treated with a monoclonal antibody, ...

  9. Publications - Janhavi Athale, M.D. - Mayo Clinic

    ... Receptor for the ICU (CAR-ICU) Initiative. Six-Year Trends in ICU Admission, Management, and Outcomes of Chimeric Antigen Receptor T-Cell Patients in the ICU.

  10. Amlodipine and valsartan (oral route) - Mayo Clinic

    Valsartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance in the body that causes blood vessels to tighten. As a result ...